SCHEMBL4378519

SCHEMBL4378519

COC(=O)c1ccc(Cl)c(-n2c(C)cc(O)cc2=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
LMNA P02545 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA7 P43166 3/20 0.41
CA9 Q16790 3/20 0.41
CA14 Q9ULX7 3/20 0.41
XDH P47989 1/20 0.41
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
MITF O75030 1/20 0.40
CASP3 P42574 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TSHR P16473 2/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4378061 0.90 ALDH1A1 (0.43) ALDH1A1LMNAL3MBTL1CA12CA1
SCHEMBL2706645 0.87 ALDH1A1 (0.60) ALDH1A1LMNAL3MBTL1CA12CA1
SCHEMBL4466843 0.85 ALDH1A1 (0.45) ALDH1A1LMNACA12CA1CA2
SCHEMBL4383585 0.85 MAPT (0.46) ALDH1A1LMNACA12CA1CA2
SCHEMBL4387429 0.84 ALDH1A1 (0.47) ALDH1A1LMNAL3MBTL1CA12CA1
SCHEMBL27621545 0.84 ALDH1A1 (0.52) ALDH1A1LMNACA12CA1CA2
SCHEMBL4380059 0.82 CYP1A2 (0.49) ALDH1A1LMNACA12CA1CA2
SCHEMBL4377003 0.80 ALDH1A1 (0.53) ALDH1A1LMNACA12CA1CA2
SCHEMBL4377764 0.79 ALDH1A1 (0.52) ALDH1A1LMNAL3MBTL1CA12CA1
SCHEMBL4379220 0.77 ALDH1A1 (0.50) ALDH1A1LMNACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
EP-1490064-B1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE PHARMACIA CORP (US) 2009-11-18 EP disclosed
US-7067540-B2 Substituted pyridinones PHARMACIA CORPORATION (US) 2006-06-27 US disclosed
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058964-A1 Substituted pyridinones MAPK1, MAPK6, MAPK7 ALDH1A1 787/4885LMNA 1815/4885L3MBTL1 3937/4885
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 ALDH1A1 741/4885LMNA 1884/4885L3MBTL1 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.